The patient's insurance company refuses to pay for the brand name formulation of a prescribed drug. Which formulation of the drug will the patient receive instead?

Choice A reason: Trade names are brand-specific; insurance denial of the brand rules this out, as it’s the costly formulation they won’t cover for the patient. Choice B reason: Generic drugs, bioequivalent to brands, cost less; insurance favors them, ensuring the same active ingredient and efficacy at a lower price point. Choice C reason: Chemical names describe molecular structure, not a formulation; they’re not dispensed as drugs, making this irrelevant to insurance or pharmacy. Choice D reason: Proprietary is synonymous with brand; if insurance denies the brand, this option is also excluded, leaving generic as the viable substitute.